Drugs / WT-gag-TCR modified T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00991224 | Nov 2009 → Jan 2014 | HIV infectious disease | University of Pennsylvania | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WT-gag-TCR modified T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00991224 ↗ |
| Action | Deplete | “they kill cells that are infected with HIV better than normal CD8 T-cells can.” NCT00991224 ↗ |
| Modality | Cell therapy | “WT-gag-TCR modified autologous T cells” NCT00991224 ↗ |